Clinical Trials Directory

Trials / Unknown

UnknownNCT06103526

Immunonutrition in ERAS Protocols in Gynecologic Oncology

Immunonutrition and Enhanced Recovery After Surgery Protocols in Gynecologic Oncology

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
National and Kapodistrian University of Athens · Academic / Other
Sex
Female
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A patient with oncological pathology of any type because of impaired digestion and nutrient absorption, decreased intake, and increased nutrition requirements has an increased risk of malnutrition and moderate to severe weight loss.In the present study the investigators will evaluate the impact of perioperative immunonutrition supplementation on the postoperative outcomes.

Detailed description

Malnutrition has a major effect not only on the postoperative course of cancer surgery but can also complicate or even limit administration or compromise the effectiveness of other treatments such as chemotherapy or radiotherapy in the perioperative period. Immunonutrition is a type of artificial nutrition based on the use of some types of macro- or micronutrients.The purpose of this review was to evaluate the use, indications, and effects of these formulas in oncologic surgical patients in real time and to identify the types of patients who can benefit from enteral immunonutrition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTImmunonutritionenteral supplementation with high amount of proteins, arginine, glutamine, nonessential fatty acids, branched chain fatty acids, nucleotides, or RNA

Timeline

Start date
2023-10-18
Primary completion
2025-05-30
Completion
2025-08-30
First posted
2023-10-26
Last updated
2024-03-28

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06103526. Inclusion in this directory is not an endorsement.